Detalhe da pesquisa
1.
Interventional Radiotherapy (Brachytherapy) in Eyelid and Ocular Surface Tumors: A Review for Treatment of Naïve and Recurrent Malignancies.
Neurosignals
; 30(S1): 1-10, 2022 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35333486
2.
The role of retinal imaging in the management of abusive head trauma cases.
Int J Legal Med
; 136(4): 1009-1016, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35072750
3.
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
JAMA
; 328(4): 348-359, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881122
4.
International Classification of Retinopathy of Prematurity, Third Edition.
Ophthalmology
; 128(10): e51-e68, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247850
5.
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.
Lancet
; 394(10208): 1551-1559, 2019 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522845
6.
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings.
Ophthalmology
; 125(2): 218-226, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28867130
7.
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
Ophthalmology
; 121(11): 2212-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25001158
8.
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia.
Paediatr Anaesth
; 24(4): 400-5, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24354865
9.
Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal Implications.
Semin Ophthalmol
; : 1-6, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502067
10.
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.
EClinicalMedicine
; 71: 102567, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38638400
11.
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
JAMA Netw Open
; 7(4): e248383, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687481
12.
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Eye (Lond)
; 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200320
14.
Avascular Peripheral Retina in Infants.
Turk J Ophthalmol
; 53(1): 44-57, 2023 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36847634
15.
Telemedicine retinopathy of prematurity severity score (TeleROP-SS) versus modified activity score (mROP-ActS) retrospective comparison in SUNDROP cohort.
Sci Rep
; 13(1): 15219, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37709791
16.
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial.
Ophthalmol Retina
; 6(7): 628-637, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202890
17.
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm Neonates.
Front Pediatr
; 10: 814194, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35223696
18.
Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity.
Ophthalmology
; 118(1): 168-75, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20709401
19.
Incidence and risk factors of retinopathy of prematurity in an Italian cohort of preterm infants.
Ital J Pediatr
; 47(1): 64, 2021 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712037
20.
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial.
Lancet Child Adolesc Health
; 5(10): 698-707, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391532